Detalhe da pesquisa
1.
Prescriber perceptions of boxed warnings: A qualitative study.
Pharmacoepidemiol Drug Saf
; 33(3): e5766, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418933
2.
Trend changes of national zolpidem users and exposure cases after FDA drug safety communications.
Pharmacoepidemiol Drug Saf
; 30(11): 1551-1559, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382718
3.
Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies.
Pharmacoepidemiol Drug Saf
; 30(7): 899-909, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33885214
4.
Use of Time-Dependent Propensity Scores to Adjust Hazard Ratio Estimates in Cohort Studies with Differential Depletion of Susceptibles.
Epidemiology
; 31(1): 82-89, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31569120
5.
Changes in emergency department visits for zolpidem-attributed adverse drug reactions after FDA Drug Safety Communications.
Pharmacoepidemiol Drug Saf
; 29(3): 352-356, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32483401
6.
Long-Term Risk of Acute Myocardial Infarction, Stroke, and Death With Outpatient Use of Clarithromycin: A Retrospective Cohort Study.
Am J Epidemiol
; 187(4): 786-792, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29036565
7.
The impact of FDA regulatory activities on incident dispensing of LABA-containing medication: 2005-2011.
J Asthma
; 55(8): 907-914, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28910559
8.
Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications.
Pharmacoepidemiol Drug Saf
; 26(6): 712-721, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28449404
9.
Media Coverage of FDA Drug Safety Communications about Zolpidem: A Quantitative and Qualitative Analysis.
J Health Commun
; 22(5): 365-372, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28339323
10.
Changing patterns of asthma medication use related to US Food and Drug Administration long-acting ß2-agonist regulation from 2005-2011.
J Allergy Clin Immunol
; 137(3): 710-7, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26725997
11.
Trends in rates of acetaminophen-related adverse events in the United States.
Pharmacoepidemiol Drug Saf
; 25(5): 590-8, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26530380
12.
Long-acting beta2-adrenergic agonist in pediatric and adolescent asthma patients, 2003-2011.
J Asthma
; 51(10): 1061-7, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24945885
13.
Risk of acute myocardial infarction, stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers - a cohort study using the Clinical Practice Research Datalink.
Pharmacoepidemiol Drug Saf
; 23(4): 340-7, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24285502
14.
Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers.
Pharmacoepidemiol Drug Saf
; 23(4): 331-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24277678
15.
Trends in Use and Evidence of Adherence to Risk Evaluation and Mitigation Strategy Pregnancy Testing Requirements for Thalidomide, Lenalidomide, and Pomalidomide in the USA, 2000-2020.
Drug Saf
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38755509
16.
How Do Risk Evaluation and Mitigation Strategies Impact Clinical Practice? A National Survey of Physicians.
Clin Pharmacol Ther
; 115(6): 1293-1303, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38375585
17.
Antidepressant medication dispensing among montelukast initiators.
J Asthma
; 50(9): 990-5, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23841530
18.
Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States.
Pharmacoepidemiol Drug Saf
; 22(12): 1251-7, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23913625
19.
The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory Activities.
Pharmaceut Med
; 37(5): 349-353, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421560
20.
Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemic.
Clin Toxicol (Phila)
; 61(3): 190-199, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892525